Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-27
2005-09-27
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S341000, C514S397000, C546S118000, C546S271400, C548S312100
Reexamination Certificate
active
06949564
ABSTRACT:
The present invention provides NPY-5 receptor antagonists having a Formula (IA)Methods and pharmaceutical compositions useful for treating diseases, conditions and/or disorders modulated by the above NPY-5 receptor antagonists are also provided.
REFERENCES:
patent: 5576337 (1996-11-01), Bruns, Jr. et al.
patent: 2004/0067999 (2004-04-01), Block et al.
patent: 0759441 (1997-02-01), None
patent: WO 9901128 (1999-01-01), None
Harfenist et al. et al, Selective inhibitors of Monoamine Oxidase. 3. Structure—Activity Relationship of Tricyclics Bearing Imidazoline, Oxadiazoe, or Tetrazole Groups. Journal of Medicinal Chemistry 1996, 39(9), 1857-63.
A. Balasubramaniam, Am. J. of Surgery, 183, pp. 430-434, 2002.
Flood and Mortey Peptides, 10, pp. 963-966, 1989.
Leibowitz and Alexander, Peptides, 12, pp. 1251-1260, 1991.
Stanley et al., Peptides, 13, pp. 581-587, 1992.
McCauley and Westfal, J. Pharmacol, Exp. Ther. 261, pp. 863-868, 1992.
Grundemar et al., Br. J. Pharmacol, 105, pp. 45-50, 1992.
Grundemar and Hakanson, TIPS, May 1994, vol. 15, pp. 153-159.
Wahlestedt et al., Regul. Peptides, 13, pp. 307-318, 1986.
Redrobe et al., Life Sciences, 71, pp. 2921-2937, 2002.
Chemical Abstracts, vol. 124, No. 11, 1996, Columbus, Ohio, U.S.; abstract No. 146013g, Berghot, Moged Ahmed et al., “Facile Synthesis of Nevl Carbazoles Through Heterocyclization Reactions and Their Antimicrobial Activity”, XP002277868.
Abstract and Rev. Roum. Chim., vol. 40, No. 4, 1995, pp 377-386, and Database Caplux “online” Chemical Abstracts Service, Columbus, Ohio, U.S., Database Accession No. 124:146013, XP002277869, Compound with RN 173463-46-2.
Hammond M. et al., Bioorganic & Medicinal Chemistry Letters, 2003, vol. 13, No. 8, pp 1989-1992, “Structure-Activity Relationships in a Series of NPY Y5 Antagonists: 3-Amido-ethylcarbazoles, Core-Modified Analogues and Amide Isosteres”.
Benson Gregg C.
Musser Arlene K.
Pfizer Inc.
Saeed Kamal A.
LandOfFree
NPY-5 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NPY-5 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NPY-5 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3418845